As of September 2026, 76 paid clinical trials are recruiting in Myrtle Beach, South Carolina. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Myrtle Beach offers studies at sites including Carolina Urologic Research Center for conditions such as Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Non-muscle Invasive Bladder Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Researchers run research studies in Myrtle Beach, SC at 23 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Carolina Urologic Research Center | Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Prostate Cancer (Adenocarcinoma) | 31 |
| Carolina Urologic Research Center, LLC | Non-muscle Invasive Bladder Cancer, Advanced Renal Cell Carcinoma, Advanced Renal Cell Carcinoma (RCC) | 10 |
| Parkway Surgery Center | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, Cancer of the Prostate | 6 |
| Grand Strand Medical Center | Acute Lower Limb Arterial Occlusion, Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma | 5 |
| START Carolinas | Bladder (Urothelial, Transitional Cell) Cancer, Metastatic Castration Resistant Prostate Cancer, NMIBC | 3 |
| Trial Management Associates | Cardiovascular Risk, Obesity, Obesity or Overweight | 3 |
| AUC Urologists, LLC | Metastatic Castration-Resistant Prostate Cancer, Non-muscle Invasive Bladder Cancer | 2 |
| Atlantic Urology Specialists | Carcinoma of the Prostate, Diagnostic Imaging, Elevated PSA | 2 |
| GSK Investigational Site | Influenza, Human, Neoplasms | 2 |
| South Texas Accelerated Research Therapeutics - Carolinas | Metastatic Castration-resistant Prostate Cancer, Metastatic Hormone-sensitive Prostate Cancer (mHSPC) | 2 |
| AMR Clinical South Strand, South Carolina | Hidradenitis Suppurativa | 1 |
| Avenzo Therapeutics Recruiting Site | Locally Advanced, Metastatic Solid Tumors, Solid Tumor Cancer | 1 |
| Carolina Regional Cancer Center | Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 | 1 |
| Carolina Urologic Research Center, the START Center for Cancer Research | Metastatic Castration-Resistant Prostate Cancer Patients, Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, mCRPC | 1 |
| Coastal Eye Group | Non-muscle Invasive Bladder Cancer | 1 |
| Exelixis Clinical | Clear Cell Renal Cell Carcinoma (ccRCC), Colorectal Cancer (CRC), Drug-Drug Interaction (DDI) | 1 |
| NEO-811 South Carolina Site | Clear Cell Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Metastatic, Kidney Cancer Metastatic | 1 |
| OrthoSC | Degenerative Disc Disease | 1 |
| START - Carolinas | Bladder (Urothelial, Transitional Cell) Cancer, Non-Muscle Invasive Bladder Carcinoma, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ | 1 |
| Site 02-006 - Carolina Urologic Research Center | Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG | 1 |
| TMA Headlands LLC (d/b/a Trial Management Associates) | Pneumococcal Disease | 1 |
| TMA Headlands LLC | Hypothyroidism | 1 |
| Vanda Investigational Site | Insomnia Disorder | 1 |
Recruiting trials in Myrtle Beach grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 76 recruiting clinical trials in Myrtle Beach, South Carolina listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Myrtle Beach compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Myrtle Beach include Prostate Cancer (11), Metastatic Castration-Resistant Prostate Cancer (4), Metastatic Castration-resistant Prostate Cancer (4), Non-muscle Invasive Bladder Cancer (3), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Myrtle Beach on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Myrtle Beach include Carolina Urologic Research Center, Carolina Urologic Research Center, LLC, Parkway Surgery Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Myrtle Beach are Cancer & tumors (54), Diabetes & metabolic (5), Vaccines (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.